The isolation and detection of pancuronium bromide was developed for aged autopsy samples to identify and confirm this compound in questioned tissue samples. A novel protocol was optimized for the isolation of the target drug in highly decomposed tissues. Solid-phase extraction (SPE) cartridges containing styrene-divinylbenzene were investigated. This polymer retained quaternary drugs and facilitated sequential elution upon washing with commonly available solvents. The semi-purified SPE samples were prescreened by pyrolysis GC-MS. A candidate specimen was then confirmed by microbore high-performance liquid chromatography/electrospray-ionization/mass spectrometry (microHPLC-ESI-MS/MS) with a triple-quadrupole mass spectrometer. The developed procedures provided a qualitative or semiquantitative (at best) basis for the investigation of difficult cases involving overdoses of polar drugs.

Download full-text PDF

Source

Publication Analysis

Top Keywords

pancuronium bromide
8
aged autopsy
8
bromide pavulon
4
pavulon isolation
4
isolation identification
4
identification aged
4
autopsy tissues
4
tissues fluids
4
fluids isolation
4
isolation detection
4

Similar Publications

Article Synopsis
  • The study aimed to identify and evaluate reports of hearing impairment related to drugs approved in the last 20 years to enhance treatment safety.
  • It analyzed adverse event data from the FAERS database and focused on "hearing disorders" to find potential new adverse reactions linked to specific medications.
  • The findings highlighted the top five drugs most associated with hearing impairment incidents and identified new signals for drugs not previously linked to this side effect, indicating a need for caution with commonly prescribed medications.
View Article and Find Full Text PDF
Article Synopsis
  • * A new compound called ExBP3C was developed as an effective reversal agent for multiple NMBAs, showing strong binding capabilities with agents like atracurium and rocuronium.
  • * ExBP3C demonstrated better efficiency than the existing reversal drug sugammadex, and in tests, it rapidly corrected heart rate issues caused by an overdose of atracurium within two minutes, indicating good safety and biocompatibility.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers have created new acyclic cucurbit[]urils (acCBs) that can quickly reverse effects of common nondepolarizing neuromuscular blocking agents (NMBAs).
  • The modified version (FY 3451) shows significantly improved activity and high water solubility, demonstrating effective results in animal studies with rats.
  • At certain doses, FY 3451 outperforms existing reversal agent sugammadex in terms of recovery time from some NMBAs like rocuronium and cisatracurium.
View Article and Find Full Text PDF

The prevalence of morbid obesity in today's population around the world is alarming. Morbid obesity involves substantial changes in body composition and function, which can affect the pharmacodynamics and pharmacokinetics of many drugs. This paper aims to discuss the application of muscle relaxants and their reversing agents in patients with morbid obesity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!